LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine

European Journal of Pharmacology

Volumn 388, Issue 2, 2000, Pages

  Schreiber, Rudy ^a   Lowe, David ^a   Voerste, Arnd ^a   De Vry, Jean ^a  

^a BAYER AG   (Germany)

Author keywords

Drug discrimination; Glutamate receptor; Metabotropic; Schizophrenia

Indexed keywords

EGLUMETAD; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR; PHENCYCLIDINE;

ANIMAL EXPERIMENT; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SHORT SURVEY; STARTLE REFLEX;

EID: 0033959387     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00844-4     Document Type: Article

References (7)

1. Bakshi V.P., Swerdlow N.R., Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J. Pharmacol. Exp. Ther. 271:1994;787.
2. 1A receptor agonist BAY×3702 in the rat. Eur. J. Pharmacol. 357:1998;1.
3. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301.
4. Koek W. N-methyl-D-aspartate antagonists and drug discrimination. Pharmacol. Biochem. Behav. 64:1999;275.
5. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science. 281:1998;1349.
6. Moore N.A., Rees G., Monn J.A. Effects of the group II metabotropic glutamate receptor agonist, LY354740 on schedule-controlled behaviour in rats. Behav. Pharmacol. 10:1999;319.
7. Schoepp D.D., Johnson B.G., Wright R.A., Salhoff C.R., Mayne N.G., Wu S., Cockerham S.L., Burnett J.P., Belegaje R., Bleakman D., Monn J.A. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology. 36:1997;1.